[144] LeMaitre Vascular, Inc. SEC Filing

Rhea-AI Filing Summary

LeMaitre Vascular (LMAT) submitted a Form 144 reporting a proposed sale of 939 shares of common stock with an aggregate market value of $87,784.39. The notice names Morgan Stanley Smith Barney LLC as broker and lists the approximate sale date as 08/08/2025 on NASDAQ, and shows 22,637,522 shares outstanding.

The filing states the securities were acquired on 08/08/2025 by a stock option exercise from the issuer and paid in cash. The section for securities sold in the past three months is marked "Nothing to Report". The form includes the standard attestation that the seller does not possess undisclosed material adverse information and references Rule 144 disclosure requirements.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for 939 shares acquired by option exercise; no recent disposals reported—unlikely to be market-moving.

The filing documents a proposed sale of 939 common shares with an aggregate value of $87,784.39 and lists Morgan Stanley Smith Barney LLC as the broker for an expected NASDAQ sale on 08/08/2025. The seller reports acquisition by stock option exercise and payment in cash, and the filing shows "Nothing to Report" for sales in the past three months. Based solely on the disclosure, this appears to be an ordinary insider/affiliate liquidation notice under Rule 144 rather than a material corporate development.

Corporate Governance Expert

TL;DR: Disclosure complies with Rule 144 formalities and includes the attestation about material nonpublic information; identification fields in the excerpt are limited.

The document includes the required attestation that the person for whose account securities will be sold does not know material adverse information and references 10b5-1 trading plan disclosure language. The provided excerpt shows broker details and transaction mechanics (option exercise, cash payment) but does not present identifying details for the seller in the visible text. From a governance and compliance perspective, the form records the necessary transaction facts but the excerpted content limits visibility into the filer identity and broader context.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	939	87784.39	22637522	08/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/08/2025	Stock Option Exercise	Issuer			939	08/08/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)